

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of sequestering of triglyceride (GO:0010889) | 6.57824828 |
| 2 | triglyceride catabolic process (GO:0019433) | 6.19869898 |
| 3 | low-density lipoprotein particle clearance (GO:0034383) | 6.01770076 |
| 4 | acylglycerol catabolic process (GO:0046464) | 5.58050314 |
| 5 | neutral lipid catabolic process (GO:0046461) | 5.58050314 |
| 6 | L-phenylalanine metabolic process (GO:0006558) | 5.30638101 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.30638101 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.14903262 |
| 9 | regulation of cholesterol esterification (GO:0010872) | 5.11359392 |
| 10 | L-phenylalanine catabolic process (GO:0006559) | 5.01458921 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.01458921 |
| 12 | low-density lipoprotein particle remodeling (GO:0034374) | 4.67326498 |
| 13 | aromatic amino acid family catabolic process (GO:0009074) | 4.54319093 |
| 14 | diacylglycerol metabolic process (GO:0046339) | 4.42938780 |
| 15 | glycerolipid catabolic process (GO:0046503) | 4.38384495 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 4.28172695 |
| 17 | reverse cholesterol transport (GO:0043691) | 4.27645112 |
| 18 | tryptophan catabolic process (GO:0006569) | 4.20043360 |
| 19 | indole-containing compound catabolic process (GO:0042436) | 4.20043360 |
| 20 | indolalkylamine catabolic process (GO:0046218) | 4.20043360 |
| 21 | brown fat cell differentiation (GO:0050873) | 4.19401810 |
| 22 | aldehyde catabolic process (GO:0046185) | 4.16901619 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.10424533 |
| 24 | exogenous drug catabolic process (GO:0042738) | 4.04457875 |
| 25 | glyoxylate metabolic process (GO:0046487) | 4.03779532 |
| 26 | kynurenine metabolic process (GO:0070189) | 4.03539123 |
| 27 | plasma lipoprotein particle remodeling (GO:0034369) | 4.03356975 |
| 28 | protein-lipid complex remodeling (GO:0034368) | 4.03356975 |
| 29 | macromolecular complex remodeling (GO:0034367) | 4.03356975 |
| 30 | fatty acid homeostasis (GO:0055089) | 3.93079186 |
| 31 | amino-acid betaine metabolic process (GO:0006577) | 3.91456413 |
| 32 | drug catabolic process (GO:0042737) | 3.89518135 |
| 33 | tyrosine metabolic process (GO:0006570) | 3.87554496 |
| 34 | fatty acid transmembrane transport (GO:1902001) | 3.85712563 |
| 35 | bile acid biosynthetic process (GO:0006699) | 3.85644996 |
| 36 | glycine metabolic process (GO:0006544) | 3.82974169 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 3.81750135 |
| 38 | aromatic amino acid family metabolic process (GO:0009072) | 3.74248003 |
| 39 | cysteine metabolic process (GO:0006534) | 3.71375241 |
| 40 | triglyceride homeostasis (GO:0070328) | 3.70408601 |
| 41 | acylglycerol homeostasis (GO:0055090) | 3.70408601 |
| 42 | ethanol oxidation (GO:0006069) | 3.70102707 |
| 43 | behavioral response to nicotine (GO:0035095) | 3.67151670 |
| 44 | regulation of triglyceride catabolic process (GO:0010896) | 3.61183902 |
| 45 | response to dietary excess (GO:0002021) | 3.60629765 |
| 46 | amine catabolic process (GO:0009310) | 3.59288681 |
| 47 | cellular biogenic amine catabolic process (GO:0042402) | 3.59288681 |
| 48 | ribosomal small subunit assembly (GO:0000028) | 3.57449073 |
| 49 | ethanol metabolic process (GO:0006067) | 3.55745858 |
| 50 | glycerol metabolic process (GO:0006071) | 3.53663036 |
| 51 | cellular glucuronidation (GO:0052695) | 3.53498204 |
| 52 | lipid particle organization (GO:0034389) | 3.53193264 |
| 53 | carnitine metabolic process (GO:0009437) | 3.52065179 |
| 54 | lipid storage (GO:0019915) | 3.51800830 |
| 55 | omega-hydroxylase P450 pathway (GO:0097267) | 3.49617428 |
| 56 | regulation of fibrinolysis (GO:0051917) | 3.49216174 |
| 57 | viral transcription (GO:0019083) | 3.48414837 |
| 58 | L-methionine salvage (GO:0071267) | 3.42556295 |
| 59 | L-methionine biosynthetic process (GO:0071265) | 3.42556295 |
| 60 | amino acid salvage (GO:0043102) | 3.42556295 |
| 61 | vitamin A metabolic process (GO:0006776) | 3.41967078 |
| 62 | response to nitrosative stress (GO:0051409) | 3.41630866 |
| 63 | sulfur amino acid catabolic process (GO:0000098) | 3.41523893 |
| 64 | negative regulation of fibrinolysis (GO:0051918) | 3.38608850 |
| 65 | triglyceride biosynthetic process (GO:0019432) | 3.38272194 |
| 66 | acylglycerol biosynthetic process (GO:0046463) | 3.37988683 |
| 67 | neutral lipid biosynthetic process (GO:0046460) | 3.37988683 |
| 68 | phospholipid efflux (GO:0033700) | 3.37931219 |
| 69 | valine metabolic process (GO:0006573) | 3.36837813 |
| 70 | white fat cell differentiation (GO:0050872) | 3.34187159 |
| 71 | serine family amino acid metabolic process (GO:0009069) | 3.34085957 |
| 72 | alpha-amino acid catabolic process (GO:1901606) | 3.32826595 |
| 73 | DNA deamination (GO:0045006) | 3.31609656 |
| 74 | translational termination (GO:0006415) | 3.31522131 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 3.29444584 |
| 76 | glucuronate metabolic process (GO:0019585) | 3.28406673 |
| 77 | uronic acid metabolic process (GO:0006063) | 3.28406673 |
| 78 | short-chain fatty acid metabolic process (GO:0046459) | 3.27709831 |
| 79 | alpha-linolenic acid metabolic process (GO:0036109) | 3.27305936 |
| 80 | negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804) | 3.26297458 |
| 81 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.25816593 |
| 82 | serine family amino acid biosynthetic process (GO:0009070) | 3.24941906 |
| 83 | regulation of lipoprotein metabolic process (GO:0050746) | 3.24713911 |
| 84 | sodium-independent organic anion transport (GO:0043252) | 3.24631166 |
| 85 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.23217931 |
| 86 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.22403664 |
| 87 | response to phenylpropanoid (GO:0080184) | 3.21488561 |
| 88 | regulation of glycogen (starch) synthase activity (GO:2000465) | 3.21202619 |
| 89 | positive regulation of lipid storage (GO:0010884) | 3.19838443 |
| 90 | transcytosis (GO:0045056) | 3.19396242 |
| 91 | homocysteine metabolic process (GO:0050667) | 3.18249205 |
| 92 | S-adenosylmethionine metabolic process (GO:0046500) | 3.13569774 |
| 93 | regulation of triglyceride metabolic process (GO:0090207) | 3.12827701 |
| 94 | alditol metabolic process (GO:0019400) | 3.12576725 |
| 95 | bile acid metabolic process (GO:0008206) | 3.12453249 |
| 96 | positive regulation of respiratory burst (GO:0060267) | 3.11351641 |
| 97 | cellular amino acid catabolic process (GO:0009063) | 3.11296621 |
| 98 | cholesterol catabolic process (GO:0006707) | 3.10609665 |
| 99 | sterol catabolic process (GO:0016127) | 3.10609665 |
| 100 | positive regulation of fatty acid oxidation (GO:0046321) | 3.09686808 |
| 101 | purine ribonucleotide transport (GO:0015868) | 3.09593579 |
| 102 | regulation of triglyceride biosynthetic process (GO:0010866) | 3.09497527 |
| 103 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.09339558 |
| 104 | urea cycle (GO:0000050) | 3.08895542 |
| 105 | urea metabolic process (GO:0019627) | 3.08895542 |
| 106 | fatty acid catabolic process (GO:0009062) | 3.08464499 |
| 107 | regulation of protein activation cascade (GO:2000257) | 3.08345577 |
| 108 | plasma lipoprotein particle organization (GO:0071827) | 3.08119673 |
| 109 | phosphatidic acid biosynthetic process (GO:0006654) | 3.07692652 |
| 110 | phosphatidic acid metabolic process (GO:0046473) | 3.07692652 |
| 111 | positive regulation of glycolytic process (GO:0045821) | 3.07137342 |
| 112 | phospholipid homeostasis (GO:0055091) | 3.06221839 |
| 113 | primary alcohol catabolic process (GO:0034310) | 3.05867574 |
| 114 | triglyceride metabolic process (GO:0006641) | 3.05674149 |
| 115 | cotranslational protein targeting to membrane (GO:0006613) | 3.03253945 |
| 116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.03117496 |
| 117 | fatty acid beta-oxidation (GO:0006635) | 3.02895347 |
| 118 | biotin metabolic process (GO:0006768) | 3.02310648 |
| 119 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.02275869 |
| 120 | plasma lipoprotein particle assembly (GO:0034377) | 3.01379970 |
| 121 | cellular ketone body metabolic process (GO:0046950) | 3.00217653 |
| 122 | arginine metabolic process (GO:0006525) | 3.00140030 |
| 123 | indolalkylamine metabolic process (GO:0006586) | 2.99603908 |
| 124 | negative regulation of response to food (GO:0032096) | 2.98883108 |
| 125 | negative regulation of appetite (GO:0032099) | 2.98883108 |
| 126 | arginine catabolic process (GO:0006527) | 2.97098052 |
| 127 | epoxygenase P450 pathway (GO:0019373) | 2.96587074 |
| 128 | * retinol metabolic process (GO:0042572) | 2.96209092 |
| 129 | monocarboxylic acid catabolic process (GO:0072329) | 2.95570973 |
| 130 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 2.95174630 |
| 131 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.95172257 |
| 132 | protein targeting to ER (GO:0045047) | 2.94756174 |
| 133 | oxidative demethylation (GO:0070989) | 2.93691953 |
| 134 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.93207482 |
| 135 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.93207482 |
| 136 | gap junction assembly (GO:0016264) | 2.92667102 |
| 137 | * primary alcohol metabolic process (GO:0034308) | 2.92007670 |
| 138 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.91726719 |
| 139 | branched-chain amino acid catabolic process (GO:0009083) | 2.90735760 |
| 140 | lysine catabolic process (GO:0006554) | 2.90674653 |
| 141 | lysine metabolic process (GO:0006553) | 2.90674653 |
| 142 | plasma lipoprotein particle clearance (GO:0034381) | 2.90669233 |
| 143 | ketone body metabolic process (GO:1902224) | 2.89854172 |
| 144 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.89144567 |
| 145 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.88865930 |
| 146 | detection of light stimulus involved in visual perception (GO:0050908) | 2.88865930 |
| 147 | cofactor catabolic process (GO:0051187) | 2.88364937 |
| 148 | negative regulation of protein autophosphorylation (GO:0031953) | 2.88357043 |
| 149 | negative regulation of cholesterol transport (GO:0032375) | 2.87991615 |
| 150 | negative regulation of sterol transport (GO:0032372) | 2.87991615 |
| 151 | cholesterol efflux (GO:0033344) | 2.87403872 |
| 152 | organic acid catabolic process (GO:0016054) | 2.87118839 |
| 153 | carboxylic acid catabolic process (GO:0046395) | 2.87118839 |
| 154 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.87046726 |
| 155 | protein-lipid complex subunit organization (GO:0071825) | 2.86370736 |
| 156 | acylglycerol metabolic process (GO:0006639) | 2.86052470 |
| 157 | regulation of cholesterol metabolic process (GO:0090181) | 2.85091995 |
| 158 | L-serine metabolic process (GO:0006563) | 2.85043148 |
| 159 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.84467240 |
| 160 | protein localization to endoplasmic reticulum (GO:0070972) | 2.84001240 |
| 161 | regulation of complement activation (GO:0030449) | 2.83831677 |
| 162 | nitrogen cycle metabolic process (GO:0071941) | 2.83378782 |
| 163 | neutral lipid metabolic process (GO:0006638) | 2.82128609 |
| 164 | acyl-CoA metabolic process (GO:0006637) | 2.81466462 |
| 165 | thioester metabolic process (GO:0035383) | 2.81466462 |
| 166 | polyketide metabolic process (GO:0030638) | 2.81052605 |
| 167 | doxorubicin metabolic process (GO:0044598) | 2.81052605 |
| 168 | daunorubicin metabolic process (GO:0044597) | 2.81052605 |
| 169 | positive regulation of glomerulus development (GO:0090193) | 2.79209910 |
| 170 | drug metabolic process (GO:0017144) | 2.76001897 |
| 171 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.74316836 |
| 172 | alanine transport (GO:0032328) | 2.73127318 |
| 173 | regulation of cholesterol storage (GO:0010885) | 2.71442552 |
| 174 | protein heterotrimerization (GO:0070208) | 2.69175566 |
| 175 | acetyl-CoA metabolic process (GO:0006084) | 2.67929810 |
| 176 | positive regulation of protein kinase C signaling (GO:0090037) | 2.65390257 |
| 177 | polyol transport (GO:0015791) | 2.64933574 |
| 178 | somite development (GO:0061053) | 2.64793348 |
| 179 | alkaloid metabolic process (GO:0009820) | 2.63676258 |
| 180 | positive regulation of lipid catabolic process (GO:0050996) | 2.62811432 |
| 181 | NADH metabolic process (GO:0006734) | 2.60469286 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.76595671 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.98689224 |
| 3 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 4.82324255 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.62565192 |
| 5 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.42996880 |
| 6 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.36600036 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.09550103 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.94214364 |
| 9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.57708338 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.42364633 |
| 11 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.19496401 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.17928356 |
| 13 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.08106373 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.91573145 |
| 15 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.75097644 |
| 16 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.71510348 |
| 17 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.68045287 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.38915291 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28277764 |
| 20 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.24842178 |
| 21 | VDR_22108803_ChIP-Seq_LS180_Human | 2.21102825 |
| 22 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.18544006 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.17391963 |
| 24 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.16710689 |
| 25 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.16634871 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.07683794 |
| 27 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 2.00964281 |
| 28 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.98075228 |
| 29 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.94344452 |
| 30 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.92184569 |
| 31 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.91034213 |
| 32 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.82441598 |
| 33 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.81733274 |
| 34 | * HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.76958021 |
| 35 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74144489 |
| 36 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.73979935 |
| 37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.71498341 |
| 38 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.70644602 |
| 39 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.69202593 |
| 40 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.69117338 |
| 41 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.68320441 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.67563583 |
| 43 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.66826831 |
| 44 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.66402793 |
| 45 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.61449582 |
| 46 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.56819986 |
| 47 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.56590703 |
| 48 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52390719 |
| 49 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.52038355 |
| 50 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.49868101 |
| 51 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.47765860 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.46207295 |
| 53 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.39731859 |
| 54 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.38981246 |
| 55 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.38538870 |
| 56 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.38506386 |
| 57 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.37348106 |
| 58 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.35394629 |
| 59 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.33629473 |
| 60 | ERA_21632823_ChIP-Seq_H3396_Human | 1.32834729 |
| 61 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.29670023 |
| 62 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.29573178 |
| 63 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.29431889 |
| 64 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26532884 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.24714079 |
| 66 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.24609459 |
| 67 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.24609459 |
| 68 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.22819607 |
| 69 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21382536 |
| 70 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.19004996 |
| 71 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.18548642 |
| 72 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.17868690 |
| 73 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.17279106 |
| 74 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.16911813 |
| 75 | TAF2_19829295_ChIP-Seq_ESCs_Human | 1.16856142 |
| 76 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.15945569 |
| 77 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.15424791 |
| 78 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.14908822 |
| 79 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.14755996 |
| 80 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.13709668 |
| 81 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.13647608 |
| 82 | NANOG_20526341_ChIP-Seq_ESCs_Human | 1.13488534 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 1.13481530 |
| 84 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.12659316 |
| 85 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.12289338 |
| 86 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12200455 |
| 87 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11438636 |
| 88 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11333569 |
| 89 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.10902416 |
| 90 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.10847712 |
| 91 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.08828895 |
| 92 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.08828895 |
| 93 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.08288278 |
| 94 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.08045097 |
| 95 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.07864098 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.07829921 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.07640840 |
| 98 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.07197896 |
| 99 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06398220 |
| 100 | P300_19829295_ChIP-Seq_ESCs_Human | 1.05649697 |
| 101 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.04218961 |
| 102 | AR_25329375_ChIP-Seq_VCAP_Human | 1.04145568 |
| 103 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.03987920 |
| 104 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.03164247 |
| 105 | CJUN_26792858_Chip-Seq_BT549_Human | 1.02030458 |
| 106 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.01610748 |
| 107 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.01369182 |
| 108 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00656187 |
| 109 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 1.00358185 |
| 110 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00295670 |
| 111 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.00201598 |
| 112 | CBP_21632823_ChIP-Seq_H3396_Human | 0.99404451 |
| 113 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.99399768 |
| 114 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 0.99327530 |
| 115 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.98611184 |
| 116 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.98577593 |
| 117 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.98338236 |
| 118 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.98337306 |
| 119 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.98255393 |
| 120 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.98069913 |
| 121 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 0.97191137 |
| 122 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.97072992 |
| 123 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96887352 |
| 124 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.96610027 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 0.96352480 |
| 126 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.95068360 |
| 127 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94671456 |
| 128 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.94585375 |
| 129 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.94208652 |
| 130 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.93539591 |
| 131 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93413938 |
| 132 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.93283055 |
| 133 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.91813002 |
| 134 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.91324968 |
| 135 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 0.91299073 |
| 136 | STAT3_23295773_ChIP-Seq_U87_Human | 0.91091499 |
| 137 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.90891399 |
| 138 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.90637560 |
| 139 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.90637560 |
| 140 | FUS_26573619_Chip-Seq_HEK293_Human | 0.90600629 |
| 141 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.90274273 |
| 142 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.90264530 |
| 143 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.89739349 |
| 144 | AR_20517297_ChIP-Seq_VCAP_Human | 0.88813083 |
| 145 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88716782 |
| 146 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88453578 |
| 147 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.88379885 |
| 148 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.88049923 |
| 149 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.87144024 |
| 150 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87123929 |
| 151 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87123929 |
| 152 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86348392 |
| 153 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.86308604 |
| 154 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.86276919 |
| 155 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.85982956 |
| 156 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.85475642 |
| 157 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.85172597 |
| 158 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 0.85089874 |
| 159 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.84859899 |
| 160 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.84759151 |
| 161 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.81146619 |
| 162 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78018176 |
| 163 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.76091708 |
| 164 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.76060405 |
| 165 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75659926 |
| 166 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.74619007 |
| 167 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.74240494 |
| 168 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.73724908 |
| 169 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.73339711 |
| 170 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.72893004 |
| 171 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.72863777 |
| 172 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.72771948 |
| 173 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.71609112 |
| 174 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70698761 |
| 175 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.70507727 |
| 176 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.70501942 |
| 177 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.70349539 |
| 178 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.70012021 |
| 179 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.68711400 |
| 180 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.68470166 |
| 181 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.67710489 |
| 182 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.67371729 |
| 183 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.67356149 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.12118096 |
| 2 | MP0005360_urolithiasis | 4.62715544 |
| 3 | MP0004130_abnormal_muscle_cell | 4.16379490 |
| 4 | * MP0003011_delayed_dark_adaptation | 3.86404119 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.76868633 |
| 6 | MP0004019_abnormal_vitamin_homeostasis | 3.75331756 |
| 7 | MP0009379_abnormal_foot_pigmentation | 3.73833514 |
| 8 | MP0009840_abnormal_foam_cell | 3.49581904 |
| 9 | MP0005365_abnormal_bile_salt | 3.28812180 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 3.16535100 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.90580861 |
| 12 | MP0000372_irregular_coat_pigmentation | 2.82647339 |
| 13 | MP0003136_yellow_coat_color | 2.81229399 |
| 14 | MP0003252_abnormal_bile_duct | 2.76354820 |
| 15 | MP0005332_abnormal_amino_acid | 2.70330252 |
| 16 | MP0003186_abnormal_redox_activity | 2.66525771 |
| 17 | MP0008004_abnormal_stomach_pH | 2.65216041 |
| 18 | MP0010329_abnormal_lipoprotein_level | 2.54553568 |
| 19 | MP0001764_abnormal_homeostasis | 2.40139760 |
| 20 | MP0005375_adipose_tissue_phenotype | 2.38235301 |
| 21 | MP0003959_abnormal_lean_body | 2.15063600 |
| 22 | MP0005646_abnormal_pituitary_gland | 2.03738996 |
| 23 | MP0009384_cardiac_valve_regurgitation | 2.03539678 |
| 24 | MP0001958_emphysema | 1.88150843 |
| 25 | MP0003950_abnormal_plasma_membrane | 1.86802594 |
| 26 | MP0005535_abnormal_body_temperature | 1.85434984 |
| 27 | MP0009115_abnormal_fat_cell | 1.83029330 |
| 28 | MP0005334_abnormal_fat_pad | 1.79842933 |
| 29 | MP0009697_abnormal_copulation | 1.77267458 |
| 30 | MP0003279_aneurysm | 1.75989905 |
| 31 | MP0001853_heart_inflammation | 1.75009016 |
| 32 | MP0004185_abnormal_adipocyte_glucose | 1.71498337 |
| 33 | MP0005448_abnormal_energy_balance | 1.69576625 |
| 34 | MP0000751_myopathy | 1.67054765 |
| 35 | MP0002876_abnormal_thyroid_physiology | 1.65245942 |
| 36 | MP0002970_abnormal_white_adipose | 1.59823122 |
| 37 | MP0005075_abnormal_melanosome_morpholog | 1.53848644 |
| 38 | MP0000003_abnormal_adipose_tissue | 1.51934774 |
| 39 | MP0000566_synostosis | 1.51394628 |
| 40 | MP0002138_abnormal_hepatobiliary_system | 1.51014290 |
| 41 | MP0006276_abnormal_autonomic_nervous | 1.49976255 |
| 42 | MP0000013_abnormal_adipose_tissue | 1.42670846 |
| 43 | MP0005084_abnormal_gallbladder_morpholo | 1.41010503 |
| 44 | MP0004381_abnormal_hair_follicle | 1.39072369 |
| 45 | MP0003195_calcinosis | 1.38794678 |
| 46 | MP0009764_decreased_sensitivity_to | 1.38448702 |
| 47 | MP0004215_abnormal_myocardial_fiber | 1.35679349 |
| 48 | MP0005083_abnormal_biliary_tract | 1.30334848 |
| 49 | MP0003656_abnormal_erythrocyte_physiolo | 1.30254730 |
| 50 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.28632939 |
| 51 | MP0002132_abnormal_respiratory_system | 1.28156161 |
| 52 | MP0003191_abnormal_cellular_cholesterol | 1.27135624 |
| 53 | MP0000749_muscle_degeneration | 1.26802481 |
| 54 | MP0001324_abnormal_eye_pigmentation | 1.25263195 |
| 55 | MP0001661_extended_life_span | 1.23919948 |
| 56 | MP0005408_hypopigmentation | 1.22566895 |
| 57 | MP0005452_abnormal_adipose_tissue | 1.20465149 |
| 58 | MP0002638_abnormal_pupillary_reflex | 1.19847897 |
| 59 | MP0005666_abnormal_adipose_tissue | 1.18218770 |
| 60 | MP0005379_endocrine/exocrine_gland_phen | 1.17411104 |
| 61 | MP0000609_abnormal_liver_physiology | 1.16840752 |
| 62 | MP0009643_abnormal_urine_homeostasis | 1.16728162 |
| 63 | MP0001666_abnormal_nutrient_absorption | 1.16531731 |
| 64 | MP0004145_abnormal_muscle_electrophysio | 1.15861504 |
| 65 | MP0001542_abnormal_bone_strength | 1.15621958 |
| 66 | MP0003724_increased_susceptibility_to | 1.14150530 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.14097818 |
| 68 | MP0002102_abnormal_ear_morphology | 1.13742929 |
| 69 | MP0002118_abnormal_lipid_homeostasis | 1.13119833 |
| 70 | * MP0005253_abnormal_eye_physiology | 1.11003771 |
| 71 | MP0005319_abnormal_enzyme/_coenzyme | 1.10328936 |
| 72 | MP0006036_abnormal_mitochondrial_physio | 1.07494975 |
| 73 | MP0002909_abnormal_adrenal_gland | 1.06924055 |
| 74 | MP0006138_congestive_heart_failure | 1.06193406 |
| 75 | MP0005636_abnormal_mineral_homeostasis | 1.04553642 |
| 76 | MP0003646_muscle_fatigue | 1.04154056 |
| 77 | MP0002078_abnormal_glucose_homeostasis | 1.04053681 |
| 78 | MP0003718_maternal_effect | 1.03945954 |
| 79 | MP0008775_abnormal_heart_ventricle | 1.03695367 |
| 80 | MP0005409_darkened_coat_color | 1.03636281 |
| 81 | MP0002928_abnormal_bile_duct | 1.02269184 |
| 82 | MP0000230_abnormal_systemic_arterial | 1.01198005 |
| 83 | MP0003690_abnormal_glial_cell | 1.00553526 |
| 84 | MP0000049_abnormal_middle_ear | 0.98670411 |
| 85 | MP0005395_other_phenotype | 0.96419240 |
| 86 | MP0002933_joint_inflammation | 0.95966806 |
| 87 | MP0005167_abnormal_blood-brain_barrier | 0.95183878 |
| 88 | MP0008872_abnormal_physiological_respon | 0.91932805 |
| 89 | * MP0005551_abnormal_eye_electrophysiolog | 0.91326262 |
| 90 | MP0010368_abnormal_lymphatic_system | 0.89824605 |
| 91 | MP0000015_abnormal_ear_pigmentation | 0.89823155 |
| 92 | MP0002653_abnormal_ependyma_morphology | 0.89202096 |
| 93 | MP0008469_abnormal_protein_level | 0.88884295 |
| 94 | MP0000750_abnormal_muscle_regeneration | 0.88839240 |
| 95 | MP0006072_abnormal_retinal_apoptosis | 0.88376311 |
| 96 | MP0005220_abnormal_exocrine_pancreas | 0.86762371 |
| 97 | MP0003879_abnormal_hair_cell | 0.86567040 |
| 98 | MP0002971_abnormal_brown_adipose | 0.86453027 |
| 99 | MP0005257_abnormal_intraocular_pressure | 0.86006241 |
| 100 | MP0001968_abnormal_touch/_nociception | 0.85483597 |
| 101 | MP0001440_abnormal_grooming_behavior | 0.85119500 |
| 102 | MP0005385_cardiovascular_system_phenoty | 0.84465874 |
| 103 | MP0001544_abnormal_cardiovascular_syste | 0.84465874 |
| 104 | MP0009780_abnormal_chondrocyte_physiolo | 0.80402094 |
| 105 | MP0003137_abnormal_impulse_conducting | 0.78533839 |
| 106 | MP0005503_abnormal_tendon_morphology | 0.78493439 |
| 107 | MP0005195_abnormal_posterior_eye | 0.78159059 |
| 108 | MP0004142_abnormal_muscle_tone | 0.76412797 |
| 109 | MP0005376_homeostasis/metabolism_phenot | 0.74987117 |
| 110 | MP0002733_abnormal_thermal_nociception | 0.74861771 |
| 111 | MP0005423_abnormal_somatic_nervous | 0.74419789 |
| 112 | MP0002168_other_aberrant_phenotype | 0.74199235 |
| 113 | MP0003953_abnormal_hormone_level | 0.74159807 |
| 114 | MP0005620_abnormal_muscle_contractility | 0.73962994 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.73471962 |
| 116 | MP0002736_abnormal_nociception_after | 0.73080803 |
| 117 | MP0003828_pulmonary_edema | 0.72989591 |
| 118 | MP0001502_abnormal_circadian_rhythm | 0.72694256 |
| 119 | MP0002938_white_spotting | 0.72069345 |
| 120 | MP0005266_abnormal_metabolism | 0.71700823 |
| 121 | MP0002295_abnormal_pulmonary_circulatio | 0.71280004 |
| 122 | MP0009763_increased_sensitivity_to | 0.68957061 |
| 123 | MP0003868_abnormal_feces_composition | 0.66334492 |
| 124 | MP0002108_abnormal_muscle_morphology | 0.65808909 |
| 125 | MP0009642_abnormal_blood_homeostasis | 0.65696987 |
| 126 | MP0001270_distended_abdomen | 0.64563454 |
| 127 | MP0000613_abnormal_salivary_gland | 0.63541944 |
| 128 | MP0000249_abnormal_blood_vessel | 0.62067325 |
| 129 | MP0002249_abnormal_larynx_morphology | 0.61826439 |
| 130 | MP0009053_abnormal_anal_canal | 0.61309230 |
| 131 | MP0004924_abnormal_behavior | 0.61272920 |
| 132 | MP0005386_behavior/neurological_phenoty | 0.61272920 |
| 133 | MP0001756_abnormal_urination | 0.60838425 |
| 134 | MP0000598_abnormal_liver_morphology | 0.59140062 |
| 135 | MP0002272_abnormal_nervous_system | 0.58085375 |
| 136 | MP0004043_abnormal_pH_regulation | 0.57945252 |
| 137 | MP0000343_altered_response_to | 0.57901036 |
| 138 | MP0004883_abnormal_blood_vessel | 0.57537378 |
| 139 | MP0000604_amyloidosis | 0.57218097 |
| 140 | MP0000759_abnormal_skeletal_muscle | 0.56278584 |
| 141 | MP0005171_absent_coat_pigmentation | 0.55948986 |
| 142 | MP0005197_abnormal_uvea_morphology | 0.55316576 |
| 143 | MP0008438_abnormal_cutaneous_collagen | 0.55065374 |
| 144 | MP0005670_abnormal_white_adipose | 0.54537677 |
| 145 | MP0003329_amyloid_beta_deposits | 0.52855728 |
| 146 | MP0005501_abnormal_skin_physiology | 0.50599433 |
| 147 | MP0003938_abnormal_ear_development | 0.49977635 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.49765811 |
| 149 | MP0000685_abnormal_immune_system | 0.49692544 |
| 150 | MP0005595_abnormal_vascular_smooth | 0.49481795 |
| 151 | MP0002163_abnormal_gland_morphology | 0.49283957 |
| 152 | MP0002095_abnormal_skin_pigmentation | 0.49036942 |
| 153 | MP0001986_abnormal_taste_sensitivity | 0.48516321 |
| 154 | MP0000631_abnormal_neuroendocrine_gland | 0.48128989 |
| 155 | MP0003638_abnormal_response/metabolism_ | 0.46137082 |
| 156 | MP0001663_abnormal_digestive_system | 0.46031029 |
| 157 | MP0000639_abnormal_adrenal_gland | 0.45714078 |
| 158 | MP0002136_abnormal_kidney_physiology | 0.45495695 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypoalphalipoproteinemia (HP:0003233) | 5.26412238 |
| 2 | Oligomenorrhea (HP:0000876) | 4.72364087 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.55780644 |
| 4 | Congenital stationary night blindness (HP:0007642) | 4.36254987 |
| 5 | Hypolipoproteinemia (HP:0010981) | 4.25387470 |
| 6 | Vascular calcification (HP:0004934) | 4.21102017 |
| 7 | Abnormality of renal resorption (HP:0011038) | 4.04432520 |
| 8 | Xanthomatosis (HP:0000991) | 3.86040812 |
| 9 | Prolonged partial thromboplastin time (HP:0003645) | 3.83135288 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 3.79158622 |
| 11 | Renal Fanconi syndrome (HP:0001994) | 3.73295530 |
| 12 | Cardiovascular calcification (HP:0011915) | 3.73085732 |
| 13 | Hyperglycinemia (HP:0002154) | 3.72752584 |
| 14 | Dry hair (HP:0011359) | 3.66990540 |
| 15 | Hyperglycinuria (HP:0003108) | 3.66816256 |
| 16 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.64608540 |
| 17 | Hepatic necrosis (HP:0002605) | 3.58087160 |
| 18 | Deep venous thrombosis (HP:0002625) | 3.55281523 |
| 19 | Tubulointerstitial nephritis (HP:0001970) | 3.54861458 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.48614598 |
| 21 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.45110034 |
| 22 | Hepatocellular necrosis (HP:0001404) | 3.39907407 |
| 23 | Decreased central vision (HP:0007663) | 3.36309096 |
| 24 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.31822893 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.31822893 |
| 26 | Mitochondrial inheritance (HP:0001427) | 3.27322935 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 3.19015947 |
| 28 | Attenuation of retinal blood vessels (HP:0007843) | 3.18143648 |
| 29 | Epidermoid cyst (HP:0200040) | 3.16003196 |
| 30 | Hypobetalipoproteinemia (HP:0003563) | 3.15822258 |
| 31 | Abnormal hemoglobin (HP:0011902) | 3.14971504 |
| 32 | Type 2 muscle fiber atrophy (HP:0003554) | 3.14246055 |
| 33 | Increased hepatocellular lipid droplets (HP:0006565) | 3.07066116 |
| 34 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.06353769 |
| 35 | Lipid accumulation in hepatocytes (HP:0006561) | 3.05707870 |
| 36 | Hyperalaninemia (HP:0003348) | 2.96060148 |
| 37 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.96060148 |
| 38 | Abnormality of alanine metabolism (HP:0010916) | 2.96060148 |
| 39 | Hyperammonemia (HP:0001987) | 2.94898109 |
| 40 | Chronic hepatic failure (HP:0100626) | 2.93188933 |
| 41 | Lethargy (HP:0001254) | 2.92051767 |
| 42 | Acanthosis nigricans (HP:0000956) | 2.91909718 |
| 43 | Cerebral edema (HP:0002181) | 2.91738923 |
| 44 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.87193625 |
| 45 | Delayed CNS myelination (HP:0002188) | 2.85679394 |
| 46 | Generalized aminoaciduria (HP:0002909) | 2.85610856 |
| 47 | Acute encephalopathy (HP:0006846) | 2.84830407 |
| 48 | Hypoplasia of the uterus (HP:0000013) | 2.79438587 |
| 49 | Acute necrotizing encephalopathy (HP:0006965) | 2.78231318 |
| 50 | Polyphagia (HP:0002591) | 2.77537020 |
| 51 | Hypoglycemic coma (HP:0001325) | 2.76202785 |
| 52 | Increased CSF lactate (HP:0002490) | 2.75772366 |
| 53 | Pigmentary retinal degeneration (HP:0001146) | 2.71161115 |
| 54 | Ketosis (HP:0001946) | 2.70295806 |
| 55 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.68822513 |
| 56 | Popliteal pterygium (HP:0009756) | 2.66990559 |
| 57 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.61630903 |
| 58 | Aplasia of the musculature (HP:0100854) | 2.59892719 |
| 59 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.58634786 |
| 60 | Gowers sign (HP:0003391) | 2.58360601 |
| 61 | Glycosuria (HP:0003076) | 2.55418765 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.55418765 |
| 63 | Increased intramyocellular lipid droplets (HP:0012240) | 2.54996014 |
| 64 | Increased muscle lipid content (HP:0009058) | 2.54056634 |
| 65 | Increased corneal curvature (HP:0100692) | 2.51283058 |
| 66 | Keratoconus (HP:0000563) | 2.51283058 |
| 67 | Muscle fiber atrophy (HP:0100295) | 2.50756941 |
| 68 | Hemorrhage of the eye (HP:0011885) | 2.49565778 |
| 69 | Mesangial abnormality (HP:0001966) | 2.45736766 |
| 70 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.45598783 |
| 71 | Abnormal eating behavior (HP:0100738) | 2.44327288 |
| 72 | Exertional dyspnea (HP:0002875) | 2.43061385 |
| 73 | Prominent supraorbital ridges (HP:0000336) | 2.42943704 |
| 74 | Abnormality of midbrain morphology (HP:0002418) | 2.41862602 |
| 75 | Molar tooth sign on MRI (HP:0002419) | 2.41862602 |
| 76 | Joint hemorrhage (HP:0005261) | 2.40733642 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.40080330 |
| 78 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.40080330 |
| 79 | Ketoacidosis (HP:0001993) | 2.39098654 |
| 80 | Abnormality of the fovea (HP:0000493) | 2.33128767 |
| 81 | Short middle phalanx of the 5th finger (HP:0004220) | 2.32704086 |
| 82 | Abnormality of methionine metabolism (HP:0010901) | 2.31519084 |
| 83 | Infantile muscular hypotonia (HP:0008947) | 2.30698686 |
| 84 | Pendular nystagmus (HP:0012043) | 2.30430658 |
| 85 | Pancreatic fibrosis (HP:0100732) | 2.28575910 |
| 86 | Concave nail (HP:0001598) | 2.27857156 |
| 87 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.27585586 |
| 88 | Bone cyst (HP:0012062) | 2.25683880 |
| 89 | Complement deficiency (HP:0004431) | 2.25165900 |
| 90 | CNS demyelination (HP:0007305) | 2.23732788 |
| 91 | Choroideremia (HP:0001139) | 2.22685389 |
| 92 | Abnormality of the neuromuscular junction (HP:0003398) | 2.22159995 |
| 93 | Fatigable weakness (HP:0003473) | 2.22159995 |
| 94 | Abnormality of the renal cortex (HP:0011035) | 2.20623410 |
| 95 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.20529464 |
| 96 | Aplasia of the phalanges of the hand (HP:0009802) | 2.20529464 |
| 97 | Aplasia involving bones of the extremities (HP:0009825) | 2.20529464 |
| 98 | Hydroxyprolinuria (HP:0003080) | 2.20517788 |
| 99 | Abnormality of proline metabolism (HP:0010907) | 2.20517788 |
| 100 | Pancreatic cysts (HP:0001737) | 2.18747244 |
| 101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.18547514 |
| 102 | Type II lissencephaly (HP:0007260) | 2.18249202 |
| 103 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.18017280 |
| 104 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.17917192 |
| 105 | Rib fusion (HP:0000902) | 2.17601026 |
| 106 | True hermaphroditism (HP:0010459) | 2.16525877 |
| 107 | Decreased circulating renin level (HP:0003351) | 2.16341660 |
| 108 | Myotonia (HP:0002486) | 2.15464312 |
| 109 | Hyperphosphaturia (HP:0003109) | 2.14629473 |
| 110 | Progressive macrocephaly (HP:0004481) | 2.13916930 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 2.13292568 |
| 112 | Abnormality of serum amino acid levels (HP:0003112) | 2.13198495 |
| 113 | Inability to walk (HP:0002540) | 2.12090411 |
| 114 | Adactyly (HP:0009776) | 2.10860027 |
| 115 | Renal tubular dysfunction (HP:0000124) | 2.10754626 |
| 116 | Renal cortical cysts (HP:0000803) | 2.10012550 |
| 117 | Increased serum lactate (HP:0002151) | 2.09155392 |
| 118 | Lactic acidosis (HP:0003128) | 2.08777867 |
| 119 | Fat malabsorption (HP:0002630) | 2.07907865 |
| 120 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.07889517 |
| 121 | Abnormal biliary tract physiology (HP:0012439) | 2.07715692 |
| 122 | Bile duct proliferation (HP:0001408) | 2.07715692 |
| 123 | Exercise intolerance (HP:0003546) | 2.07058282 |
| 124 | Metabolic acidosis (HP:0001942) | 2.06254726 |
| 125 | Abolished electroretinogram (ERG) (HP:0000550) | 2.04714778 |
| 126 | Insulin resistance (HP:0000855) | 2.03094986 |
| 127 | Hypoplastic left heart (HP:0004383) | 2.01954230 |
| 128 | Respiratory failure (HP:0002878) | 2.01803571 |
| 129 | Abnormality of complement system (HP:0005339) | 2.01201364 |
| 130 | Abnormality of permanent molar morphology (HP:0011071) | 2.01118503 |
| 131 | Abnormality of the dental root (HP:0006486) | 2.01118503 |
| 132 | Taurodontia (HP:0000679) | 2.01118503 |
| 133 | Nephronophthisis (HP:0000090) | 1.99688690 |
| 134 | Hypertriglyceridemia (HP:0002155) | 1.99626907 |
| 135 | Fetal akinesia sequence (HP:0001989) | 1.99392886 |
| 136 | Abnormality of molar morphology (HP:0011070) | 1.97599637 |
| 137 | Abnormality of molar (HP:0011077) | 1.97599637 |
| 138 | Nausea (HP:0002018) | 1.97430085 |
| 139 | Abnormality of the common coagulation pathway (HP:0010990) | 1.96152785 |
| 140 | Macrocytic anemia (HP:0001972) | 1.95937506 |
| 141 | Abnormality of placental membranes (HP:0011409) | 1.95439513 |
| 142 | Amniotic constriction ring (HP:0009775) | 1.95439513 |
| 143 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.94580993 |
| 144 | Respiratory difficulties (HP:0002880) | 1.94173271 |
| 145 | Vomiting (HP:0002013) | 1.93703619 |
| 146 | Abnormality of the dental pulp (HP:0006479) | 1.91916077 |
| 147 | Hypophosphatemic rickets (HP:0004912) | 1.90918681 |
| 148 | Cerebral palsy (HP:0100021) | 1.90133428 |
| 149 | Thyroid-stimulating hormone excess (HP:0002925) | 1.89799469 |
| 150 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.87744240 |
| 151 | Abnormality of nucleobase metabolism (HP:0010932) | 1.86814930 |
| 152 | Abnormality of vitamin metabolism (HP:0100508) | 1.86680662 |
| 153 | Increased purine levels (HP:0004368) | 1.86395299 |
| 154 | Skin nodule (HP:0200036) | 1.86228253 |
| 155 | Congenital, generalized hypertrichosis (HP:0004540) | 1.86036055 |
| 156 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 1.85223355 |
| 157 | Abnormal drinking behavior (HP:0030082) | 1.84591000 |
| 158 | Polydipsia (HP:0001959) | 1.84591000 |
| 159 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.82826146 |
| 160 | Macular degeneration (HP:0000608) | 1.82524273 |
| 161 | Opisthotonus (HP:0002179) | 1.81670645 |
| 162 | Easy fatigability (HP:0003388) | 1.80789006 |
| 163 | Tubular atrophy (HP:0000092) | 1.79256864 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TLK1 | 6.70019316 |
| 2 | NME2 | 4.17584047 |
| 3 | NEK9 | 3.28516385 |
| 4 | BCKDK | 3.27594039 |
| 5 | TIE1 | 2.69836154 |
| 6 | IRAK3 | 2.64640413 |
| 7 | FRK | 2.44247804 |
| 8 | CASK | 2.10645222 |
| 9 | IRAK4 | 2.07686645 |
| 10 | BMPR1B | 2.04254043 |
| 11 | TESK2 | 1.99486348 |
| 12 | STK39 | 1.83231440 |
| 13 | MAP4K2 | 1.81196413 |
| 14 | IRAK2 | 1.79846049 |
| 15 | WNK3 | 1.75637178 |
| 16 | FGFR4 | 1.72902132 |
| 17 | CAMKK2 | 1.71447905 |
| 18 | TGFBR2 | 1.69406529 |
| 19 | PIM2 | 1.68415211 |
| 20 | PRKAA2 | 1.67706850 |
| 21 | TAOK3 | 1.65418421 |
| 22 | IRAK1 | 1.62655993 |
| 23 | MAPKAPK3 | 1.59956414 |
| 24 | CAMK1 | 1.58947294 |
| 25 | WNK4 | 1.56887154 |
| 26 | KDR | 1.55668255 |
| 27 | NUAK1 | 1.51618686 |
| 28 | STK16 | 1.48756207 |
| 29 | PBK | 1.48060049 |
| 30 | EIF2AK1 | 1.47233749 |
| 31 | CCNB1 | 1.44820241 |
| 32 | MAPK15 | 1.44185157 |
| 33 | PTK6 | 1.40720639 |
| 34 | DAPK2 | 1.38546225 |
| 35 | MYLK | 1.37445922 |
| 36 | MARK1 | 1.35874420 |
| 37 | MST4 | 1.35721130 |
| 38 | DDR2 | 1.34252133 |
| 39 | TNIK | 1.33990235 |
| 40 | PDK2 | 1.22543251 |
| 41 | GRK1 | 1.17396290 |
| 42 | GRK5 | 1.16615979 |
| 43 | ADRBK2 | 1.15586167 |
| 44 | CDK19 | 1.14937646 |
| 45 | ZAK | 1.14751471 |
| 46 | MAPK13 | 1.14040971 |
| 47 | ACVR1B | 1.11330359 |
| 48 | BLK | 1.11141049 |
| 49 | PAK3 | 1.10897989 |
| 50 | MAPK12 | 1.07519398 |
| 51 | EPHA3 | 1.06360122 |
| 52 | MAP2K1 | 1.06088946 |
| 53 | EPHB2 | 1.06085807 |
| 54 | DAPK3 | 1.05258771 |
| 55 | DYRK2 | 1.03251398 |
| 56 | TBK1 | 1.03088133 |
| 57 | MAP2K2 | 0.98058547 |
| 58 | PRKCQ | 0.97806599 |
| 59 | SIK1 | 0.97682381 |
| 60 | NLK | 0.97383596 |
| 61 | ABL2 | 0.95369679 |
| 62 | PRKACG | 0.94607515 |
| 63 | MKNK2 | 0.94511697 |
| 64 | BUB1 | 0.92528497 |
| 65 | ERN1 | 0.92419524 |
| 66 | TEC | 0.90856185 |
| 67 | PIK3CG | 0.89545805 |
| 68 | VRK1 | 0.89508369 |
| 69 | LMTK2 | 0.89121249 |
| 70 | PRKAA1 | 0.88087029 |
| 71 | IKBKE | 0.88015330 |
| 72 | TESK1 | 0.87539860 |
| 73 | LIMK1 | 0.87512388 |
| 74 | MAP3K4 | 0.85811943 |
| 75 | PKN1 | 0.85252227 |
| 76 | KIT | 0.83246681 |
| 77 | NME1 | 0.81923719 |
| 78 | PHKG2 | 0.81513286 |
| 79 | PHKG1 | 0.81513286 |
| 80 | TXK | 0.81424446 |
| 81 | MAP3K11 | 0.81417838 |
| 82 | MAPK4 | 0.81384081 |
| 83 | PINK1 | 0.79991628 |
| 84 | INSRR | 0.77378931 |
| 85 | TGFBR1 | 0.76107734 |
| 86 | PRKG1 | 0.74464333 |
| 87 | ILK | 0.74130112 |
| 88 | DYRK1B | 0.70882977 |
| 89 | FLT3 | 0.70606313 |
| 90 | BTK | 0.67608033 |
| 91 | MAP2K4 | 0.67233039 |
| 92 | TSSK6 | 0.65285052 |
| 93 | ADRBK1 | 0.64440835 |
| 94 | PRKCG | 0.64384988 |
| 95 | STK11 | 0.64114919 |
| 96 | FES | 0.63998599 |
| 97 | MAP3K5 | 0.63825898 |
| 98 | TYK2 | 0.62683812 |
| 99 | MAPK11 | 0.62507396 |
| 100 | MAPK7 | 0.61926675 |
| 101 | CAMK2G | 0.61883190 |
| 102 | NEK6 | 0.61859391 |
| 103 | MOS | 0.61523219 |
| 104 | CSK | 0.60124743 |
| 105 | CSNK1G2 | 0.59632955 |
| 106 | CAMK1D | 0.59360796 |
| 107 | IKBKB | 0.58948470 |
| 108 | ZAP70 | 0.56550222 |
| 109 | LRRK2 | 0.54625647 |
| 110 | PRKACB | 0.53544744 |
| 111 | MST1R | 0.51262868 |
| 112 | CDK8 | 0.51196363 |
| 113 | PRKCD | 0.51033285 |
| 114 | MELK | 0.50440051 |
| 115 | ABL1 | 0.48048749 |
| 116 | OXSR1 | 0.47410196 |
| 117 | CAMK2A | 0.47274382 |
| 118 | PTK2B | 0.46709830 |
| 119 | PRKCE | 0.46497939 |
| 120 | CSNK2A1 | 0.45582917 |
| 121 | GSK3A | 0.45313042 |
| 122 | PIK3CA | 0.45232703 |
| 123 | AURKA | 0.45143160 |
| 124 | OBSCN | 0.45130761 |
| 125 | PRKCZ | 0.44193246 |
| 126 | MAP2K6 | 0.43739557 |
| 127 | MAPKAPK5 | 0.43689203 |
| 128 | JAK2 | 0.42717730 |
| 129 | ROCK1 | 0.42336286 |
| 130 | IGF1R | 0.41002432 |
| 131 | LYN | 0.40159084 |
| 132 | MUSK | 0.40075079 |
| 133 | PRKCA | 0.39777935 |
| 134 | LCK | 0.38143053 |
| 135 | TNK2 | 0.37681396 |
| 136 | PRKCI | 0.37344434 |
| 137 | MAP3K14 | 0.37188949 |
| 138 | MAP2K7 | 0.37157772 |
| 139 | MAP4K1 | 0.36427227 |
| 140 | MAPK3 | 0.35338133 |
| 141 | CSNK1A1 | 0.34446872 |
| 142 | CSNK2A2 | 0.33859401 |
| 143 | EIF2AK3 | 0.33761313 |
| 144 | CAMK2D | 0.33176113 |
| 145 | GRK6 | 0.32853754 |
| 146 | STK38L | 0.31987005 |
| 147 | PDPK1 | 0.31683455 |
| 148 | CSNK1D | 0.31460244 |
| 149 | DYRK1A | 0.31111497 |
| 150 | GRK7 | 0.30435429 |
| 151 | PRKACA | 0.30222189 |
| 152 | RPS6KA3 | 0.30109678 |
| 153 | NTRK3 | 0.29791116 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.13322784 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.07144966 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.73619405 |
| 4 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55684942 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.48924362 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.46896891 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.46230378 |
| 8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.30079510 |
| 9 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.26521034 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.17485835 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.12672462 |
| 12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.10295436 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.05846897 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.03150771 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99633818 |
| 16 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.97321989 |
| 17 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.94490433 |
| 18 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.88831910 |
| 19 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.87400777 |
| 20 | Sulfur relay system_Homo sapiens_hsa04122 | 1.86894784 |
| 21 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.86855749 |
| 22 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.86176122 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.83261577 |
| 24 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.80177969 |
| 25 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.76613462 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.73873137 |
| 27 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.72654199 |
| 28 | * Retinol metabolism_Homo sapiens_hsa00830 | 1.66588433 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.64746487 |
| 30 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.63440842 |
| 31 | Parkinsons disease_Homo sapiens_hsa05012 | 1.63366658 |
| 32 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.55692721 |
| 33 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.53563105 |
| 34 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.52892249 |
| 35 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52111883 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.51439848 |
| 37 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.51406766 |
| 38 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.49717266 |
| 39 | Phototransduction_Homo sapiens_hsa04744 | 1.44211194 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.40636709 |
| 41 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.37823490 |
| 42 | Histidine metabolism_Homo sapiens_hsa00340 | 1.32780396 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.31534115 |
| 44 | Protein export_Homo sapiens_hsa03060 | 1.28192633 |
| 45 | Carbon metabolism_Homo sapiens_hsa01200 | 1.25984726 |
| 46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23759936 |
| 47 | Bile secretion_Homo sapiens_hsa04976 | 1.15372756 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.14702662 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.14282365 |
| 50 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.13034639 |
| 51 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.12973809 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.11657226 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.11224167 |
| 54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09740080 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.07464914 |
| 56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.07193877 |
| 57 | Huntingtons disease_Homo sapiens_hsa05016 | 1.02605406 |
| 58 | Alzheimers disease_Homo sapiens_hsa05010 | 1.02352394 |
| 59 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.02237562 |
| 60 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.01245504 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.96884581 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95852989 |
| 63 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.93406017 |
| 64 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.93125214 |
| 65 | Metabolic pathways_Homo sapiens_hsa01100 | 0.89723119 |
| 66 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.89690122 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.89508400 |
| 68 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.88815812 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.88243018 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.87001190 |
| 71 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85860897 |
| 72 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85826043 |
| 73 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.84843092 |
| 74 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.84615658 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84489137 |
| 76 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.83459676 |
| 77 | Proteasome_Homo sapiens_hsa03050 | 0.79024107 |
| 78 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.78338008 |
| 79 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.75977318 |
| 80 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72128978 |
| 81 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.66976755 |
| 82 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.66936857 |
| 83 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.63085918 |
| 84 | Galactose metabolism_Homo sapiens_hsa00052 | 0.62779169 |
| 85 | ABC transporters_Homo sapiens_hsa02010 | 0.61159017 |
| 86 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.54459247 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.52681669 |
| 88 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49887810 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49305308 |
| 90 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.45971612 |
| 91 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.45496522 |
| 92 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.45419728 |
| 93 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.44426858 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43775672 |
| 95 | DNA replication_Homo sapiens_hsa03030 | 0.42969441 |
| 96 | Morphine addiction_Homo sapiens_hsa05032 | 0.41862355 |
| 97 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.39275127 |
| 98 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36428121 |
| 99 | Purine metabolism_Homo sapiens_hsa00230 | 0.32961573 |
| 100 | Mineral absorption_Homo sapiens_hsa04978 | 0.30091800 |
| 101 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29774801 |
| 102 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.29688480 |
| 103 | Circadian rhythm_Homo sapiens_hsa04710 | 0.27018831 |
| 104 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.25807403 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.25534951 |
| 106 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.25523530 |
| 107 | Renin secretion_Homo sapiens_hsa04924 | 0.24673290 |
| 108 | Malaria_Homo sapiens_hsa05144 | 0.22035988 |
| 109 | Homologous recombination_Homo sapiens_hsa03440 | 0.21669559 |
| 110 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.20749079 |
| 111 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.20662009 |
| 112 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.20560330 |
| 113 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20477658 |
| 114 | Lysine degradation_Homo sapiens_hsa00310 | 0.19667808 |
| 115 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.19075024 |
| 116 | Olfactory transduction_Homo sapiens_hsa04740 | 0.18764696 |
| 117 | Taste transduction_Homo sapiens_hsa04742 | 0.17815063 |
| 118 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.17609103 |
| 119 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.16253461 |
| 120 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14729154 |
| 121 | Base excision repair_Homo sapiens_hsa03410 | 0.14231800 |
| 122 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.13701898 |
| 123 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.12272218 |
| 124 | Lysosome_Homo sapiens_hsa04142 | 0.12219483 |

